Venous Therapies

This channel includes news and new technology innovations of Venous Therapies including deep vein thrombosis (DVT) and vena cava filters.

An assortment of Boston Scientific AngioJet rheolytic thrombectomy catheters. These devices use high-velocity saline jets to entrain thrombus, resulting in microfragmentation and removal. Thrombectomy is also referred to as embolectomy.

An assortment of Boston Scientific AngioJet rheolytic thrombectomy catheters. These devices use high-velocity saline jets to entrain thrombus, resulting in microfragmentation and removal.

Feature | Thrombectomy Devices | January 22, 2019 | Dave Fornell, Editor
Catheter-based blood clot removal a decade ago was a standard of care for acute coronary revascularization, but...
First BTG Sentry Bioconvertible IVC Filter Implanted in U.S.
News | Vena Cava Filters | December 04, 2018
December 4, 2018 — BTG plc announced the first patients outside of a clinical trial have been successfully implanted...
First Commercial Ekos Control Unit 4.0 Products Shipped to Europe
News | Thrombectomy Devices | November 21, 2018
November 21, 2018 — BTG plc announced the first Ekos CU 4.0 units have been shipped from BTG’s facility in Bothell,...
News | Venous Therapies | August 08, 2018
August 8, 2018 — Boston Scientific Corp. announced it has signed an agreement to acquire Veniti Inc., which has...
A patient case study showing a venous ulcer formation 18 months following thermal ablation varicose vein treatment in the GSV. The patient was treated with Varithena polidocanol endovenous microfoam chemical-ablation. Images show baseline prior to treatment (right), followed by one, four and six weeks after treatment. The treatment is also called sclerotherapy.

A patient case study showing a venous ulcer formation 18 months following thermal ablation varicose vein treatment in the GSV. The patient was treated with Varithena polidocanol endovenous microfoam chemical-ablation. Images show baseline prior to treatment (right), followed by one, four and six weeks after treatment.

Feature | Venous Therapies | April 30, 2018 | Tif Siragusa, M.D.
The introduction of thermal ablation revolutionized the treatment of varicose veins, yet recurrence remains a stubborn...
Vascade Vascular Closure System Approved for Femoral Vein Closure
Technology | Vascular Closure Devices | April 10, 2018
April 10, 2018 – Cardiva Medical announced the company received U.S. Food and Drug Administration (FDA) approval for an...
Illustration of the EkoSonic catheter aiding drug-dispersion in a DVT clot. Catheter directed thrombolysis of deep vein thrombosis.

Illustration of the EkoSonic catheter aiding drug-dispersion in a DVT clot.

Feature | Deep Vein Thrombosis (DVT) | February 16, 2018 | Sanjay Pandya, M.D.
There are few downsides to using tibial venous access to treat deep vein thrombosis (DVT) with catheter-directed...
Medtronic Launches IDE Study of Abre Venous Self-Expanding Stent
News | Venous Therapies | January 26, 2018
January 26, 2018 – Medtronic plc announced the initiation of its investigational device exemption (IDE) study for the...
Florida Law Firm Sues Cordis, Blames Death on IVC Filter
News | Vena Cava Filters | January 02, 2018
January 2, 2018 — Osborne & Associates Law Firm, P.A., of Boca Raton, Fla., has filed suit in Palm Beach Circuit...
News | Vena Cava Filters | September 26, 2017
September 26, 2017 — The one-year results of the SENTRY clinical trial were presented by principal investigator Michael...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab | September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials...
Veniti Announces Boston Scientific Distribution Agreement for Vici Venous Stent
News | Venous Therapies | September 11, 2017
September 11, 2017 — Veniti Inc. announced that Boston Scientific will distribute the Vici Venous Stent under a limited...
ACCESS PTS Study Demonstrates Efficacy of EKOS Therapy for Post-Thrombotic Syndrome
News | Deep Vein Thrombosis (DVT) | July 07, 2017
July 7, 2017 — BTG plc recently highlighted the results of the ACCESS PTS trial, presented at the Society for Vascular...
Videos | Venous Therapies | June 27, 2017
This video, provided by Ekos, demonstrates the EkoSonic endovascular System thrombolytic system to treat deep vein...
New Data Demonstrate Clinical and Quality-of-Life Benefits for VenaSeal Closure System in Venous Reflux Disease Patients
News | Venous Therapies | May 05, 2017
May 5, 2017 — Medtronic plc recently announced three-year outcomes from the VeClose U.S. pivotal clinical trial and one...